Sorry, no content matched your criteria.
Featured Story
Should I Buy Valeant Stock After Q4 2015 Earnings?
Valeant not only missed expectations in its Q4 2015 earnings report, but also provided a bleak outlook for 2016.
The drug maker has dealt with countless scandals over the past six months, which has made the Valeant stock price plunge over 78% from its 52-week high of $263.81.
Valeant not only missed expectations in its Q4 2015 earnings report, but also provided a bleak outlook for 2016.
The drug maker has dealt with countless scandals over the past six months, which has made the Valeant stock price plunge over 78% from its 52-week high of $263.81.